Allianz Asset Management Gmb H Biogen Inc. Transaction History

Allianz Asset Management Gmb H

  • $70.3 Billion
  • Q1 2025

A detailed history of Allianz Asset Management Gmb H transactions in Biogen Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 667,767 shares of BIIB stock, worth $88 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
667,767
Previous 535,954 24.59%
Holding current value
$88 Million
Previous $82 Million 11.49%
% of portfolio
0.13%
Previous 0.11%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 05, 2025
BUY
$133.43 - $153.27 $17.6 Million - $20.2 Million
131,813 Added 24.59%
667,767 $91.4 Million
Q4 2024

Feb 03, 2025
BUY
$146.47 - $191.55 $1.53 Million - $2 Million
10,441 Added 1.99%
535,954 $82 Million
Q3 2024

Nov 12, 2024
SELL
$189.07 - $236.8 $503,871 - $631,072
-2,665 Reduced 0.5%
525,513 $102 Million
Q2 2024

Aug 13, 2024
SELL
$190.52 - $236.72 $17.5 Million - $21.8 Million
-92,066 Reduced 14.84%
528,178 $122 Million
Q1 2024

May 13, 2024
SELL
$212.02 - $267.71 $20.9 Million - $26.4 Million
-98,475 Reduced 13.7%
620,244 $134 Million
Q4 2023

Feb 12, 2024
SELL
$222.59 - $267.94 $11.9 Million - $14.4 Million
-53,639 Reduced 6.94%
718,719 $186 Million
Q3 2023

Nov 13, 2023
BUY
$253.3 - $285.89 $5.1 Million - $5.76 Million
20,147 Added 2.68%
772,358 $199 Million
Q2 2023

Aug 11, 2023
BUY
$275.25 - $318.06 $14.6 Million - $16.8 Million
52,942 Added 7.57%
752,211 $214 Million
Q1 2023

May 11, 2023
BUY
$256.56 - $292.34 $30.2 Million - $34.4 Million
117,635 Added 20.22%
699,269 $194 Million
Q4 2022

Feb 13, 2023
BUY
$252.44 - $306.72 $4.22 Million - $5.12 Million
16,703 Added 2.96%
581,634 $161 Million
Q3 2022

Nov 08, 2022
SELL
$194.69 - $268.46 $6.38 Million - $8.79 Million
-32,754 Reduced 5.48%
564,931 $151 Million
Q2 2022

Aug 12, 2022
BUY
$187.54 - $223.02 $12.5 Million - $14.9 Million
66,903 Added 12.6%
597,685 $122 Million
Q1 2022

May 13, 2022
BUY
$193.77 - $244.14 $12.2 Million - $15.4 Million
62,913 Added 13.45%
530,782 $112 Million
Q4 2021

Feb 11, 2022
BUY
$223.92 - $287.77 $34.9 Million - $44.8 Million
155,845 Added 49.95%
467,869 $112 Million
Q3 2021

Nov 10, 2021
BUY
$282.99 - $369.05 $31 Million - $40.5 Million
109,683 Added 54.21%
312,024 $88.3 Million
Q2 2021

Aug 16, 2021
SELL
$259.0 - $414.71 $7.95 Million - $12.7 Million
-30,680 Reduced 13.17%
202,341 $70.1 Million
Q1 2021

May 13, 2021
SELL
$242.95 - $284.63 $29.5 Million - $34.6 Million
-121,533 Reduced 34.28%
233,021 $65.2 Million
Q4 2020

Feb 16, 2021
BUY
$236.26 - $355.63 $11.4 Million - $17.1 Million
48,058 Added 15.68%
354,554 $86.8 Million
Q3 2020

Nov 13, 2020
SELL
$264.77 - $305.71 $79.3 Million - $91.5 Million
-299,460 Reduced 49.42%
306,496 $86.9 Million
Q2 2020

Aug 14, 2020
BUY
$258.66 - $342.55 $6.03 Million - $7.98 Million
23,302 Added 4.0%
605,956 $162 Million
Q1 2020

May 14, 2020
SELL
$268.85 - $341.04 $13.7 Million - $17.4 Million
-51,071 Reduced 8.06%
582,654 $184 Million
Q4 2019

Feb 13, 2020
BUY
$220.06 - $304.07 $14.7 Million - $20.3 Million
66,855 Added 11.79%
633,725 $188 Million
Q3 2019

Nov 13, 2019
SELL
$217.44 - $243.88 $13.7 Million - $15.4 Million
-63,204 Reduced 10.03%
566,870 $132 Million
Q2 2019

Aug 08, 2019
SELL
$219.29 - $241.72 $10.5 Million - $11.6 Million
-48,065 Reduced 7.09%
630,074 $147 Million
Q1 2019

May 13, 2019
BUY
$216.71 - $338.96 $4.73 Million - $7.4 Million
21,839 Added 3.33%
678,139 $160 Million
Q4 2018

Feb 14, 2019
BUY
$278.5 - $352.75 $25.7 Million - $32.6 Million
92,416 Added 16.39%
656,300 $197 Million
Q3 2018

Nov 13, 2018
SELL
$293.51 - $383.83 $40 Million - $52.3 Million
-136,332 Reduced 19.47%
563,884 $199 Million
Q2 2018

Aug 13, 2018
SELL
$257.52 - $306.91 $21.1 Million - $25.2 Million
-81,982 Reduced 10.48%
700,216 $203 Million
Q1 2018

May 14, 2018
BUY
$260.13 - $367.91 $39.7 Million - $56.1 Million
152,461 Added 24.21%
782,198 $214 Million
Q4 2017

Feb 13, 2018
BUY
$307.64 - $344.58 $20.6 Million - $23.1 Million
67,044 Added 11.91%
629,737 $201 Million
Q3 2017

Nov 13, 2017
BUY
$281.15 - $329.69 $6.69 Million - $7.85 Million
23,796 Added 4.42%
562,693 $176 Million
Q2 2017

Aug 14, 2017
BUY
N/A
3,670 Added 0.69%
538,897 $146 Million
Q1 2017

Apr 17, 2019
SELL
N/A
-183,046 Reduced 25.48%
535,227 $146 Million
Q4 2016

Apr 17, 2019
BUY
N/A
17,447 Added 2.49%
718,273 $204 Million
Q3 2016

Apr 17, 2019
BUY
N/A
700,826
700,826 $218 Million

Others Institutions Holding BIIB

# of Institutions
1,026
Shares Held
127M
Call Options Held
2.29M
Put Options Held
4.26M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $19B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email